The non-profit entity Calibr was created by Merck and has about 150 scientists working directly
This will enable basic biomedical research for Merck and drug discovery tools for academics
This initiative would provide scientists with the required medicinal chemistry and pharmacology tools in order to develop a drug
Unlike Pfizer’s CTI, Calibr is not associated with a particular association
Academics can submit proposals, which will then be reviewed by a scientific advisory board
Calibr will not have a specific therapeutic focus
Merck, has the option of an exclusive licence on any proteins or small-molecule therapeutics
This will enable basic biomedical research for Merck and drug discovery tools for academics
This initiative would provide scientists with the required medicinal chemistry and pharmacology tools in order to develop a drug
Unlike Pfizer’s CTI, Calibr is not associated with a particular association
Academics can submit proposals, which will then be reviewed by a scientific advisory board
Calibr will not have a specific therapeutic focus
Merck, has the option of an exclusive licence on any proteins or small-molecule therapeutics